Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-dose gallium imaging in lymphoma.

K C Anderson, R C Leonard, G P Canellos

    The American Journal of Medicine
    |August 1, 1983
    PubMed
    Summary

    Gallium-67 imaging with updated techniques shows high accuracy in managing lymphoma patients. This nuclear medicine approach is valuable for assessing disease extent and treatment response, particularly in Hodgkin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2010
    Same author

    Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

    Annals of oncology : official journal of the European Society for Medical Oncology·2007
    Same author

    Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same author

    Primary treatment of Hodgkin's disease.

    Annals of oncology : official journal of the European Society for Medical Oncology·2002
    Same author

    Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease.

    Annals of oncology : official journal of the European Society for Medical Oncology·2002
    Same author

    Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

    Cancer chemotherapy and pharmacology·2001

    Area of Science:

    • Nuclear Medicine
    • Oncology
    • Diagnostic Imaging

    Background:

    • Traditional gallium-67 imaging used lower doses and rectilinear scanners for lymphoma assessment.
    • Advancements in imaging technology, including higher tracer doses and Anger cameras, prompted re-evaluation of gallium-67's role.

    Purpose of the Study:

    • To evaluate the diagnostic performance of updated gallium-67 imaging protocols in patients with lymphoma.
    • To compare gallium-67 scan results with other diagnostic modalities and clinical outcomes.

    Main Methods:

    • Utilized higher gallium-67 doses (7-10 mCi) and a triple-peak Anger camera.
    • Compared gallium scan findings in 51 non-Hodgkin's lymphoma and 21 Hodgkin's disease patients with radiologic, clinical, and histopathologic data.
    • Assessed the subsequent disease course in relation to gallium scan results.

    Main Results:

    • Achieved sensitivity and specificity of 0.90 or greater for both lymphoma types.
    • Demonstrated an overall accuracy of 96% by site.
    • Newer gallium scanning approaches showed high specificity in all lymphomas and high sensitivity in high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    • Gallium scans proved valuable for mediastinal assessment and as an adjunct for abdominal node disease evaluation.

    Conclusions:

    • Updated gallium-67 imaging is highly specific for lymphoma management.
    • It is particularly sensitive in high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    • Gallium-67 imaging serves as a valuable adjunct to CT and ultrasonography for staging and monitoring lymphoma.

    Related Experiment Videos